{"id":29297,"date":"2026-03-10T21:36:06","date_gmt":"2026-03-10T21:36:06","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/29297\/"},"modified":"2026-03-10T21:36:06","modified_gmt":"2026-03-10T21:36:06","slug":"roche-to-invest-%e2%82%a9710b-in-south-korea-over-five-years-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/29297\/","title":{"rendered":"Roche to invest \u20a9710B in South Korea over five years"},"content":{"rendered":"<p>Roche Holding AG pledged to invest \u20a9710 billion (US$484.6 million) in South Korea over the next five years, positioning the country as a major global hub for clinical trials. The near $500 million agreement inked with the Korean government will bring Roche\u2019s clinical trials for common or incurable diseases and innovative biopharmaceutical products to the country.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/86-bioworld-asia\" rel=\"nofollow noopener\" target=\"_blank\">BioWorld Asia<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/214-deals-and-m-a\" rel=\"nofollow noopener\" target=\"_blank\">Deals and M&amp;A<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/402-regulatory\" rel=\"nofollow noopener\" target=\"_blank\">Regulatory<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/393-asia-pacific\" rel=\"nofollow noopener\" target=\"_blank\">Asia-Pacific<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/567-mohw\" rel=\"nofollow noopener\" target=\"_blank\">MOHW<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holding AG pledged to invest \u20a9710 billion (US$484.6 million) in South Korea over the next five years,&hellip;\n","protected":false},"author":2,"featured_media":26214,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[941,2350,8086,15287,4067,8568,250,15998,16001,16002,5562,251,4180,134,16000,473,15999,1220],"class_list":{"0":"post-29297","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-asia-pacific","9":"tag-astrazeneca-plc","10":"tag-bioworld","11":"tag-bioworld-asia","12":"tag-clinical-trial","13":"tag-deals-and-ma","14":"tag-investment","15":"tag-konect","16":"tag-merck-kgaa","17":"tag-mohw","18":"tag-mou","19":"tag-rd","20":"tag-regulatory","21":"tag-roche","22":"tag-roche-diagnostics-korea-co-ltd","23":"tag-roche-holding-ag","24":"tag-roche-korea-co-ltd","25":"tag-south-korea"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116207038161485466","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/29297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=29297"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/29297\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/26214"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=29297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=29297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=29297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}